| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evofem Biosciences, Inc. (EVFM) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. EVFM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2021 | File Justin J. | Chief Financial Officer | Buy | 24,500 | $1.03 | $25,235.00 | +5.9% | |
| Jun 10, 2021 | Pelletier Saundra L | Chief Executive Officer | Buy | 50,000 | $1.03 | $51,500.00 | +6.2% | |
| Jun 10, 2021 | Fitzpatrick Alexander A83 | General Counsel And Secretary | Buy | 10,000 | $1.03 | $10,250.00 | +3.3% | |
| Mar 9, 2021 | Pelletier Saundra L | Chief Executive Officer | Buy | 45,249 | $2.28 | $103,167.72 | +5.3% | |
| Nov 17, 2020 | File Justin J. | Chief Financial Officer | Buy | 7,760 | $2.17 | $16,839.20 | +3.1% | |
| Nov 17, 2020 | Fitzpatrick Alexander A83 | General Counsel And Secretary | Buy | 9,090 | $2.20 | $19,998.00 | +6.8% | |
| Sep 11, 2020 | Barrans Russell | Chief Commercial Officer | Buy | 4,000 | $2.24 | $8,950.00 | +0.7% | |
| Sep 8, 2020 | Pelletier Saundra L | Chief Executive Officer | Sell | 122,500 | $3.26 | $399,350.00 | -25.3% | |
| Jun 17, 2020 | Rarick Lisa Dale | Director | Buy | 5,250 | $2.99 | $15,697.50 | New | |
| Jun 15, 2020 | Hall William Walmsley | Director | Buy | 5,000 | $2.85 | $14,250.00 | New |